Long-term retention in Office Based Opioid Treatment with buprenorphine.

about

Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine.Commentary: Providing technical assistance for the state targeted response for opioid use disorders: Time is of the essence.

P2860

Q38695672-2B7BC088-E873-42CF-B7D3-45EE5F40F35A Q52316752-E6772E6C-FF46-47BB-B3AD-8CE3548AF459

P2860

Long-term retention in Office Based Opioid Treatment with buprenorphine.

Item

http://www.wikidata.org/entity/Q36263379

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Long-term retention in Office Based Opioid Treatment with buprenorphine.

@ast

Long-term retention in Office Based Opioid Treatment with buprenorphine.

@en

type

Item

label

Long-term retention in Office Based Opioid Treatment with buprenorphine.

@ast

Long-term retention in Office Based Opioid Treatment with buprenorphine.

@en

prefLabel

Long-term retention in Office Based Opioid Treatment with buprenorphine.

@ast

Long-term retention in Office Based Opioid Treatment with buprenorphine.

@en

P1476

Long-term retention in Office Based Opioid Treatment with buprenorphine.

@en

P2093

Colleen T Labelle

http://www.w3.org/2001/XMLSchema#string

David Hui

http://www.w3.org/2001/XMLSchema#string

Debbie M Cheng

http://www.w3.org/2001/XMLSchema#string

Emily Quinn

http://www.w3.org/2001/XMLSchema#string

Hyunjoong W Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

Predictors of outpatient treatment retention: patient versus substance use characteristics.

Responses of Massachusetts hospitals to a state mandate to collect race, ethnicity and language data from patients: a qualitative study

Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience

Buprenorphine treatment of refractory depression.

Psychiatric comorbidity and the prevalence of HIV infection in a sample of patients in treatment for substance abuse.

Buprenorphine retention in primary care.

The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence.

Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty

Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study

P304

65-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JSAT.2016.12.010

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28132702

http://www.w3.org/2001/XMLSchema#string

P932

5312773

http://www.w3.org/2001/XMLSchema#string

Long-term retention in Office Based Opioid Treatment with buprenorphine.

about

P2860

P2860

Long-term retention in Office Based Opioid Treatment with buprenorphine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932